Photo credit: commons.wikimedia.org

— Warren Buffett

A long-term investment in Henry Schein Inc (NASD: HSIC) illustrates how patient stock ownership can compound capital over time, even without the benefit of dividend reinvestment. For an investor who put $10,000 into HSIC in October 2006 and simply held the shares through October 2026, the position would have grown to $42,433.13, based on the figures below.

The broader point is straightforward: short-term market volatility can obscure the economics of a multi-decade holding period. Henry Schein, a distributor of healthcare products and services with exposure to dental and medical markets, has historically been evaluated less as an income stock and more as a business tied to steady healthcare demand, operational execution, and long-run earnings growth.

HSIC 20-Year Return Details

HSIC 20-Year Return Details
Start date:	10/23/2006	$10,000 10/23/2006   $42,433 10/22/2026
End date:	10/22/2026
Start price/share:	$20.27
End price/share:	$86.00
Starting shares:	493.34
Ending shares:	493.34
Dividends reinvested/share:	$0.00
Total return:	324.27%
Average annual return:	7.49%
Starting investment:	$10,000.00
Ending investment:	$42,433.13

What Drove the Return?

The math here is simple because Henry Schein did not contribute to the result through dividends in this example. Ending shares are unchanged at 493.34, and the gain came entirely from share price appreciation, with HSIC rising from $20.27 to $86.00 over the period.

That distinction matters. Total return can come from three main sources: earnings growth, changes in valuation multiples, and capital returned to shareholders through dividends or buybacks. In this case, the reported outcome reflects a pure price-return story rather than a dividend-compounding story.

HSIC Investment Results at a Glance

• Initial investment: $10,000.00
• Ending value: $42,433.13
• Total gain: $32,433.13
• Total return: 324.27%
• Annualized return: 7.49%
• Dividend reinvestment impact in this calculation: none

How to Interpret a 7.49% Annualized Return

An annualized return of 7.49% over 20 years is a useful reminder that compounding does not need to look dramatic in any single year to produce a meaningful long-run outcome. A return in that range can more than quadruple capital across two decades, provided the holding period is long enough and the investment thesis remains intact.

It also shows why investor behavior matters. A result like this depends not only on the business and the stock, but on the willingness to remain invested through multiple market cycles, including recessions, valuation resets, and periods when the shares may lag broader benchmarks or sector peers.

What This Example Says About Long-Term Stock Ownership

Henry Schein’s 20-year return profile highlights a broader principle in equity investing: durable businesses can create substantial shareholder value over extended periods even when they are not high-yielding securities. For companies tied to essential end markets such as healthcare distribution and practice support, the long-term thesis often rests on resilience of demand, scale advantages, execution, and capital allocation discipline.

That does not mean future returns will resemble past returns. It does mean that evaluating a stock like HSIC over a full business cycle, or several of them, is generally more informative than focusing on short-term price moves.

As shown above, a $10,000 investment in Henry Schein made on 10/23/2006 would have grown to $42,433.13 by 10/22/2026, for a total return of 324.27% and an average annual return of 7.49%. [These numbers were computed with the Dividend Channel DRIP Returns Calculator.]

One final investment principle is worth keeping in view:
“Ensure management’s interests are aligned with shareholders.” — Sam Zell